Amgen Inc.

Stocks

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 21:00:00 17/07/2026 BST			5-day change	1st Jan Change
366.29 ^USD	-1.42%		+0.80%	+11.91%

07-16	Merck gets US FDA nod for first-in-its-class oral cholesterol drug	RE
07-13	BofA Securities Adjusts Amgen Price Target to $312 From $307	MT

Transcript : Amgen Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 09

Published on 06/09/2026 at 03:35 pm BST - Modified on 06/09/2026 at 05:50 pm BST

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Salveen Richter (Analysts)

Good morning. Thank you for joining us. It's my pleasure to introduce the Amgen team. With us, we have Peter Griffith, Chief Financial Officer; Murdo Gordon,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Amgen Inc.

07-16	Merck gets US FDA nod for first-in-its-class oral cholesterol drug	RE
07-13	BofA Securities Adjusts Amgen Price Target to $312 From $307	MT
07-13	UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating	MT
07-08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT
07-08	Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating	MT
07-07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
07-07	Truist Securities Adjusts Amgen Price Target to $340 From $327	MT
07-06	Rothschild & Co Redburn Adjusts Price Target on Amgen to $220 From $200	MT
07-03	Amgen Inc. Announces Product Recall	CI
07-03	Amgen, Inc. Announces Product Recall	CI
07-03	Amgen Inc Recalls Sensipar Tablets 30 mg, 30-Count Bottles Due to CGMP Deviations	CI
07-03	Amgen Inc Announces Product Recall	CI
07-03	Amgen Recalls Corlanor Tablets Due to Presence of Foreign Substance	CI
07-02	Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug	MT
07-02	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial	DJ